Medical risk and therapeutic effectiveness of rapid smoking

Hall, Robert G.; Sachs, David P.L.; Hall, Sharon M.

doi:10.1016/s0005-7894(79)80042-8

Cited by 35 publications

(13 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Rapid smoking procedures entail smoking a large amount in a short period of time (Hall et al 1979). Because the rapid smoking procedure exaggerates the impact of both pharmacological and sensory effects of smoking, the model might be useful for examining further the role of pharmacological versus sensory effects in craving suppression.…”

Section: Introductionmentioning

confidence: 99%

Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking

et al. 2003

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking

et al. 2003

View full text Add to dashboard Cite

show abstract

“…The great risks possible in rapid smoking methods lead to cautionary notes (Horan, Hackett, Nicholas, Linberg, Stone and Lukaski, 1974;Hauser, 1974). Other reports investigating the effects of rapid smoking acknowledge the risks, but point to rapid smoking as a beneficial method for healthy subjects (Hall, Sachs and Hall, 1979). Some researchers have attempted to develop safe alternative methods for acquiring a smoking aversion (Hackett and Horan, 1978).…”

Section: Smoking Cessation Methodsmentioning

confidence: 99%

Nicotine fading, behavioral contracting, and extended treatment: Effects on smoking cessation

Bowers

Winett

Frederiksen

1987

Addictive Behaviors

View full text Add to dashboard Cite

Twenty-eight subjects were randomly allocated to either a nicotine fading or a maintenance condition. The maintenance condition utilized behavioral contracting and extended treatment in addition to the nicotine fading to improve treatment outcome and avoid relapse. The maintenance condition achieved superior outcome on smoking measures at post-treatment and follow-up periods for self-reported smoking levels. Carbon monoxide levels were significantly lower for the maintenance condition at post-treatment, three month and six month follow-up. Saliva thiocyanate levels were significantly lower for the maintenance condition at the three month follow-up. Changes in health functioning indicated significantly lower diastolic and systolic blood pressure at six month follow-up for the maintenance condition. Additional research on nicotine regulation during nicotine fading and thiocyanate levels during experimental smoking would be useful. The use of behavioral contracting to enhance maintenance without therapeutic support warrants further research as well.

show abstract

“…Smoking conditions were identical to those employed previously (Hall et al, 1979;Sachs et al, 1978) and included a normal smoking session during which subjects smoked three cigarettes at a rate of 1 inhalation/min and a rapid smoking session during which the subject inhaled every 6 s on cue from a continuous tape loop. During rapid smoking subjects were instructed to continue until they felt they were unable to smoke without vomiting or passing out.…”

Section: Methodsmentioning

confidence: 99%

Two-year efficacy and safety of rapid smoking therapy in patients with cardiac and pulmonary disease.

Hall¹,

Sachs²,

Hall³

et al. 1984

Journal of Consulting and Clinical Psychology

Self Cite

View full text Add to dashboard Cite

Eighteen smokers with documented cardiopulmonary disease underwent rapid smoking therapy with follow-up visits 12-and 24-months posttreatment. Biochemically verified self-report showed 50% of all subjects had not smoked from posttreatment through the 2-year follow-up visit, whereas a waiting-list control group had 0% abstinent subjects at the 2-year follow-up visit (p < .0001). The same 18 smokers and an additional 3 smokers all with documented cardiac and/or pulmonary disease underwent extensive cardiac testing and monitoring after 12 hr of tobacco abstinence, normal smoking, and rapid smoking. No subject developed evidence of myocardial ischemia or significant cardiac arrhythmia during normal or rapid smoking. These findings support the use of the original method and its safe and effective use in patients with mild to moderate cardiopulmonary disease and those who have had previous, uncomplicated heart attacks.

show abstract

Medical risk and therapeutic effectiveness of rapid smoking

Cited by 35 publications

References 24 publications

Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking

Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking

Nicotine fading, behavioral contracting, and extended treatment: Effects on smoking cessation

Two-year efficacy and safety of rapid smoking therapy in patients with cardiac and pulmonary disease.

Contact Info

Product

Resources

About